| Gastrointestinal infections (amoebiasis, giardiasis) |
| Urinary tract infections |
| Gynecological infections |
| Mixed bacterial and protozoal infections |
| Post-surgical prophylaxis |
Tablet
This fixed-dose combination provides dual coverage against bacterial and protozoal pathogens. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, while Tinidazole, a nitroimidazole derivative, disrupts DNA synthesis in anaerobic bacteria and protozoa.
| Speciality | Gastroenterology | Urology | Gynecology | General Medicine |
|---|---|
| Tags | Antibiotic | Antiprotozoal | GI Infections | UTI |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.